uniQure
QURE
13,07 €
Share price
-1.50%
Change (1 day)
198.32%
Change (1 year)
Market capitalization of uniQure (QURE)
Market cap: €0.71 Billion
As of June 2025 uniQure has a market cap of €0.71 Billion. This makes uniQure the world's 6017th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of uniQure from 2014 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | €0.71 B | -12.68% |
| 2024 | €0.81 B | 179.95% |
| 2023 | €0.29 B | -70.41% |
| 2022 | €0.98 B | 16.9% |
| 2021 | €0.84 B | -35.25% |
| 2020 | €1.30 B | -53.26% |
| 2019 | €2.79 B | 197.16% |
| 2018 | €0.94 B | 87.12% |
| 2017 | €0.50 B | 275.77% |
| 2016 | €0.13 B | -63.64% |
| 2015 | €0.36 B | 67.11% |
| 2014 | €0.22 B |
End of Day market cap according to different sources
On Jun 16th, 2025 the market cap of uniQure was reported to be:
€0.71 Billion
€0.71 Billion
Market capitalization for similar companies or competitors
| Name | Marketcap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | €137.50 B | 19,111.17% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | €0.10 B | -85.17% | 🇺🇸 USA |
 bluebird bio
BLUE | €42.1 M | -94.12% | 🇺🇸 USA |
 Avidity Biosciences RNA | €3.10 B | 334.15% | 🇺🇸 USA |
 Sanofi SNY | €106.05 B | 14,717.87% | 🇫🇷 France |
 BioMarin Pharmaceutical BMRN | €9.33 B | 1,203.78% | 🇺🇸 USA |